OncoImmunology
Volume 11, 2022 - Issue 1
Open access
4,527
Views
6
CrossRef citations to date
0
Altmetric
REVIEW
PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
Peng Liua Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France;b Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138 and CNRS SNC 5096, Institut Universitaire de France, Paris, FranceView further author information
, Jianzhou Chenc INSERM U1015, Equipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, FranceView further author information
, Liwei Zhaoa Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France;b Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138 and CNRS SNC 5096, Institut Universitaire de France, Paris, FranceView further author information
, Antoine Hollebecqued Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, FranceView further author information
, Oliver Keppa Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France;b Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138 and CNRS SNC 5096, Institut Universitaire de France, Paris, FranceCorrespondence[email protected]
https://orcid.org/0000-0002-6081-9558View further author information
Laurence Zitvogelc INSERM U1015, Equipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France;d Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France;e Gustave Roussy, ClinicObiome, Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, FranceCorrespondence[email protected]
View further author information
& View further author information
Guido Kroemera Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France;b Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138 and CNRS SNC 5096, Institut Universitaire de France, Paris, France;g Institut du Cancer Paris CARPEM, Department of Biology, APHP, Hôpital Européen Georges Pompidou, Paris, FranceCorrespondence[email protected]
View further author information
show allView further author information
Article: 2093518
|
Received 16 Jun 2022, Accepted 20 Jun 2022, Published online: 24 Jun 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.